BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7509849)

  • 1. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease.
    Bondareff W; Harrington C; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1994 Mar; 53(2):158-64. PubMed ID: 7509849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.
    Brion JP; Hanger DP; Bruce MT; Couck AM; Flament-Durand J; Anderton BH
    Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):127-33. PubMed ID: 1899184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau immunoreactivity and SDS solubility of two populations of paired helical filaments that differ in morphology.
    Ksiezak-Reding H; Morgan K; Dickson DW
    Brain Res; 1994 Jun; 649(1-2):185-96. PubMed ID: 7953631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
    Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
    Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.
    Endoh R; Ogawara M; Iwatsubo T; Nakano I; Mori H
    Brain Res; 1993 Jan; 601(1-2):164-72. PubMed ID: 8431763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual enhancement of double immunofluorescent signals by CARD: participation of ubiquitin during formation of neurofibrillary tangles.
    Uchihara T; Nakamura A; Nagaoka U; Yamazaki M; Mori O
    Histochem Cell Biol; 2000 Dec; 114(6):447-51. PubMed ID: 11201605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioglioma with neurofibrillary tangles (NFTs): neoplastic NFTs share antigenic determinants with NFTs of Alzheimer's disease.
    Soffer D; Umansky F; Goldman JE
    Acta Neuropathol; 1995; 89(5):451-3. PubMed ID: 7542425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease.
    Brion JP; Couck AM; Robertson J; Loviny TL; Anderton BH
    J Neurochem; 1993 Apr; 60(4):1372-82. PubMed ID: 7681101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules.
    Ikegami K; Kimura T; Katsuragi S; Ono T; Yamamoto H; Miyamoto E; Miyakawa T
    Psychiatry Clin Neurosci; 1996 Jun; 50(3):137-40. PubMed ID: 9201760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.
    Bondareff W; Wischik CM; Novak M; Amos WB; Klug A; Roth M
    Am J Pathol; 1990 Sep; 137(3):711-23. PubMed ID: 2169192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.
    Spillantini MG; Crowther RA; Goedert M
    Acta Neuropathol; 1996 Jul; 92(1):42-8. PubMed ID: 8811124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
    J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
    Layfield R; Fergusson J; Aitken A; Lowe J; Landon M; Mayer RJ
    Neurosci Lett; 1996 May; 209(1):57-60. PubMed ID: 8734909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease.
    Uboga NV; Price JL
    Neurobiol Aging; 2000; 21(1):1-10. PubMed ID: 10794842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
    Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
    J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.